A Point Biopharma Global cancer therapy key to a $1.4 billion Eli Lilly M&A deal has met the main goal of its pivotal clinical trial in prostate cancer. But the results raise questions about how well ...
Why would any healthy person, newly diagnosed with cancer, elect not to undergo curative treatment? Newly diagnosed prostate cancer patients presented with the option of active surveillance often ask ...
BEDFORD, Mass., and INDIANAPOLIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- December 18, 2023 – Lantheus Holdings, Inc. (LNTH) (Lantheus) and POINT Biopharma Global Inc. (POINT) (NASDAQ: PNT) today announced ...
Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.
Vitamin E Supplements May Raise the Risk for Prostate Cancer Updated results from the SELECT trial show that not only does vitamin E not prevent prostate cancer, supplementation might actually elevate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results